J Knee Surg 2019; 32(06): 554-559
DOI: 10.1055/s-0038-1660477
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Medium- to Long-Term Results of the Nexgen Legacy Posterior Stabilized Fixed-Bearing Knee Replacement

Oommen Mathew Arikupurathu
1   University Department of Orthopaedic and Trauma Surgery, Tayside Orthopaedic and Rehabilitation Centre (TORT), Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom
,
Linda Johnston
1   University Department of Orthopaedic and Trauma Surgery, Tayside Orthopaedic and Rehabilitation Centre (TORT), Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom
,
Alasdair MacInnes
2   Directorate of Orthopaedic and Trauma Surgery, Ninewells Hospital and Medical School, Dundee, United Kingdom
,
Graeme Nicol
2   Directorate of Orthopaedic and Trauma Surgery, Ninewells Hospital and Medical School, Dundee, United Kingdom
,
Manhal Nassif
3   Directorate of Orthopaedic and Trauma Surgery, Perth Royal Infirmary, Taymount Terrace, Perth, United Kingdom
› Institutsangaben
Weitere Informationen

Publikationsverlauf

10. Oktober 2017

26. April 2018

Publikationsdatum:
20. Juni 2018 (online)

Abstract

The NexGen legacy posterior stabilized (LPS) prosthesis was introduced in 1997 after many design changes to its predecessor, the Insall–Burstein II prosthesis. However, there have been no reported long-term studies on the performance of this implant. Prospectively, collected data from a local database comprising primary total knee replacements (TKRs) with LPS between 1997 and 2002 was analyzed. All implants were fixed with cement. Patients were followed up at 1, 3, 5, 7, and 10 years, with patient satisfaction, range of movement, and Knee Society score (KSS) assessed. A total of 621 primary TKRs were analyzed with an average follow-up of 11.25 years (9.15–14.55). The mean age was 69.53 years. The mean KSS was 88.97 and mean flexion increased from 88.3 to 103.5 degrees at 10 years. Kaplan–Meier's analysis revealed a survivorship of 96.5% with revision for any reason as the end point and 98.9% if aseptic loosening was the reason for revision at 14 years. This study revealed excellent mid- to long-term results with the NexGen LPS prosthesis.

 
  • References

  • 1 Kim S. Changes in surgical loads and economic burden of hip and knee replacements in the US: 1997-2004. Arthritis Rheum 2008; 59 (04) 481-488
  • 2 Vazquez-Vela Johnson G, Worland RL, Keenan J, Norambuena N. Patient demographics as a predictor of the ten-year survival rate in primary total knee replacement. J Bone Joint Surg Br 2003; 85 (01) 52-56
  • 3 Ip D, Wu WC, Tsang WL. Early results of posterior-stabilised NexGen Legacy total knee arthroplasty. J Orthop Surg (Hong Kong) 2003; 11 (01) 38-42
  • 4 Nutton RW, van der Linden ML, Rowe PJ, Gaston P, Wade FA. A prospective randomised double-blind study of functional outcome and range of flexion following total knee replacement with the NexGen standard and high flexion components. J Bone Joint Surg Br 2008; 90 (01) 37-42
  • 5 Zaki SH, Rafiq I, Kapoor A, Raut V, Gambhir AK, Porter ML. Medium-term results with the Press Fit Condylar (PFC) Sigma knee prosthesis the Wrightington experience. Acta Orthop Belg 2007; 73 (01) 55-59
  • 6 Laskin RS. The Genesis total knee prosthesis: a 10-year followup study. Clin Orthop Relat Res 2001; (388) 95-102
  • 7 Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res 1989; (248) 13-14
  • 8 Chiu KY, Ng TP, Tang WM, Yau WP. Review article: knee flexion after total knee arthroplasty. J Orthop Surg (Hong Kong) 2002; 10 (02) 194-202
  • 9 Oh KJ, Goodman SB, Yang JH. Prospective, randomized study between Insall-Burstein II and NexGen legacy with a minimum 9-year follow-up. J Arthroplasty 2011; 26 (08) 1232-1238
  • 10 Schrama JC, Espehaug B, Hallan G. , et al. Risk of revision for infection in primary total hip and knee arthroplasty in patients with rheumatoid arthritis compared with osteoarthritis: a prospective, population-based study on 108,786 hip and knee joint arthroplasties from the Norwegian Arthroplasty Register. Arthritis Care Res (Hoboken) 2010; 62 (04) 473-479
  • 11 Rowley DI, McGurty DW. A seven-year experience of data collection on the Insall-Burstein II total knee arthroplasty. A prospective study. J Bone Joint Surg Br 2001; 83 (02) 185-190
  • 12 Kavolus CH, Hummel MT, Barnett KP, Jennings Jr JE. Comparison of the Insall-Burstein II and NexGen legacy total knee arthroplasty systems with respect to patella complications. J Arthroplasty 2008; 23 (06) 822-825
  • 13 Berger RA, Rosenberg AG, Barden RM, Sheinkop MB, Jacobs JJ, Galante JO. Long-term follow up of the Miller- Galante total knee replacement. Clin Orthop Relat Res 2001; 388: 58-67
  • 14 Rodriguez JA, Bhende H, Ranawat C. Total Condylar Knee Replacement: A 20-Year Followup Study. Clin Orthop Rel Res 2001; 388: 10-17
  • 15 Park JW, Kim YH. Simultaneous cemented and cementless total knee replacement in the same patients: a prospective comparison of long-term outcomes using an identical design of NexGen prosthesis. J Bone Joint Surg Br 2011; 93 (11) 1479-1486